![Microorganisms | Free Full-Text | Genome Evolution of Filamentous Cyanobacterium Nostoc Species: From Facultative Symbiosis to Free Living | HTML Microorganisms | Free Full-Text | Genome Evolution of Filamentous Cyanobacterium Nostoc Species: From Facultative Symbiosis to Free Living | HTML](https://www.mdpi.com/microorganisms/microorganisms-09-02015/article_deploy/html/images/microorganisms-09-02015-g001-550.jpg)
Microorganisms | Free Full-Text | Genome Evolution of Filamentous Cyanobacterium Nostoc Species: From Facultative Symbiosis to Free Living | HTML
Identification of Inhibitors of SARS-CoV-2 3CL-Pro Enzymatic Activity Using a Small Molecule in Vitro Repurposing Screen | ACS Pharmacology & Translational Science
![Sustainability | Free Full-Text | Measures to Increase Local Food Supply in the Context of European Framework Scenarios for the Agri-Food Sector | HTML Sustainability | Free Full-Text | Measures to Increase Local Food Supply in the Context of European Framework Scenarios for the Agri-Food Sector | HTML](https://www.mdpi.com/sustainability/sustainability-13-10019/article_deploy/html/images/sustainability-13-10019-g001.png)
Sustainability | Free Full-Text | Measures to Increase Local Food Supply in the Context of European Framework Scenarios for the Agri-Food Sector | HTML
![Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial - The Lancet Oncology Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial - The Lancet Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2594baee-07e9-4e40-9888-16b8c07060cb/gr1_lrg.gif)